Novo CEO pressed by Senate to cut selling prices of being overweight, diabetes medicine CEO Lars Fruergaard Jørgensen advised lawmakers the corporate would consider new talks with insurers concerning the listing costs of Wegovy and copyright should they pledge to maintain the medicines on their formularies. UnitedHealth sues CMS more https://labelthefigurewiththeitem60504.blog-gold.com/37882579/healthcare-news-an-overview